Aspartame: Scientific Evaluation in the Postmarketing Period

Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Regulatory toxicology and pharmacology 2001-12, Vol.34 (3), p.221-233
Hauptverfasser: Butchko, Harriett H., Stargel, W.Wayne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 233
container_issue 3
container_start_page 221
container_title Regulatory toxicology and pharmacology
container_volume 34
creator Butchko, Harriett H.
Stargel, W.Wayne
description Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer.
doi_str_mv 10.1006/rtph.2001.1500
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72385919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0273230001915004</els_id><sourcerecordid>18224948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</originalsourceid><addsrcrecordid>eNqF0DFP3DAUwHGroioH7dqxygJbjvfsOI4Ry-lEKRJSkWhny9gvYJpLDttB4ts36Z3EhOrFy-892X_GviIsEaA-i3n7uOQAuEQJ8IEtEHRdAtfygC2AK1FyAXDIjlJ6AgDeNOoTO0RUspJcLdjFKm1tzHZD58WdC9Tn0AZXXL7YbrQ5DH0R-iI_UnE7pLyx8Q_l0D8UtxTD4D-zj63tEn3Z38fs9_fLX-sf5c3Pq-v16qZ0FWAu60ojr6eDSrSN0C1C7YgIa-nQVkKre_KNU56o8tpq5SxIclZ4Lrn2KI7Z6W7vNg7PI6VsNiE56jrb0zAmo7hopEb9X4gN55Wumgkud9DFIaVIrdnGMH3v1SCYOayZw5o5rJnDTgPf9pvH-w35N74vOYGTPbDJ2a6NtnchvTlRScB_rtk5moK9BIomzdkd-RDJZeOH8N4b_gIBK5M9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18224948</pqid></control><display><type>article</type><title>Aspartame: Scientific Evaluation in the Postmarketing Period</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Butchko, Harriett H. ; Stargel, W.Wayne</creator><creatorcontrib>Butchko, Harriett H. ; Stargel, W.Wayne</creatorcontrib><description>Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer.</description><identifier>ISSN: 0273-2300</identifier><identifier>EISSN: 1096-0295</identifier><identifier>DOI: 10.1006/rtph.2001.1500</identifier><identifier>PMID: 11754527</identifier><identifier>CODEN: RTOPDW</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Animals ; aspartame ; Aspartame - administration &amp; dosage ; Aspartame - adverse effects ; Aspartame - chemistry ; Australia ; Biological and medical sciences ; Brazil ; Centers for Disease Control and Prevention (U.S.) - statistics &amp; numerical data ; Europe ; food additives ; Food Industry - statistics &amp; numerical data ; Food toxicology ; Humans ; Medical sciences ; Nutrition Policy ; Product Surveillance, Postmarketing - standards ; Product Surveillance, Postmarketing - statistics &amp; numerical data ; sweeteners ; Toxicology ; United States ; United States Food and Drug Administration - statistics &amp; numerical data</subject><ispartof>Regulatory toxicology and pharmacology, 2001-12, Vol.34 (3), p.221-233</ispartof><rights>2001 Elsevier Science (USA)</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</citedby><cites>FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/rtph.2001.1500$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13450127$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11754527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Butchko, Harriett H.</creatorcontrib><creatorcontrib>Stargel, W.Wayne</creatorcontrib><title>Aspartame: Scientific Evaluation in the Postmarketing Period</title><title>Regulatory toxicology and pharmacology</title><addtitle>Regul Toxicol Pharmacol</addtitle><description>Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer.</description><subject>Animals</subject><subject>aspartame</subject><subject>Aspartame - administration &amp; dosage</subject><subject>Aspartame - adverse effects</subject><subject>Aspartame - chemistry</subject><subject>Australia</subject><subject>Biological and medical sciences</subject><subject>Brazil</subject><subject>Centers for Disease Control and Prevention (U.S.) - statistics &amp; numerical data</subject><subject>Europe</subject><subject>food additives</subject><subject>Food Industry - statistics &amp; numerical data</subject><subject>Food toxicology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Nutrition Policy</subject><subject>Product Surveillance, Postmarketing - standards</subject><subject>Product Surveillance, Postmarketing - statistics &amp; numerical data</subject><subject>sweeteners</subject><subject>Toxicology</subject><subject>United States</subject><subject>United States Food and Drug Administration - statistics &amp; numerical data</subject><issn>0273-2300</issn><issn>1096-0295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0DFP3DAUwHGroioH7dqxygJbjvfsOI4Ry-lEKRJSkWhny9gvYJpLDttB4ts36Z3EhOrFy-892X_GviIsEaA-i3n7uOQAuEQJ8IEtEHRdAtfygC2AK1FyAXDIjlJ6AgDeNOoTO0RUspJcLdjFKm1tzHZD58WdC9Tn0AZXXL7YbrQ5DH0R-iI_UnE7pLyx8Q_l0D8UtxTD4D-zj63tEn3Z38fs9_fLX-sf5c3Pq-v16qZ0FWAu60ojr6eDSrSN0C1C7YgIa-nQVkKre_KNU56o8tpq5SxIclZ4Lrn2KI7Z6W7vNg7PI6VsNiE56jrb0zAmo7hopEb9X4gN55Wumgkud9DFIaVIrdnGMH3v1SCYOayZw5o5rJnDTgPf9pvH-w35N74vOYGTPbDJ2a6NtnchvTlRScB_rtk5moK9BIomzdkd-RDJZeOH8N4b_gIBK5M9</recordid><startdate>20011201</startdate><enddate>20011201</enddate><creator>Butchko, Harriett H.</creator><creator>Stargel, W.Wayne</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20011201</creationdate><title>Aspartame: Scientific Evaluation in the Postmarketing Period</title><author>Butchko, Harriett H. ; Stargel, W.Wayne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-649126666173f839f106ceee165c1a4397bed8c7dee4d9a97ca05eca3d2529d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>aspartame</topic><topic>Aspartame - administration &amp; dosage</topic><topic>Aspartame - adverse effects</topic><topic>Aspartame - chemistry</topic><topic>Australia</topic><topic>Biological and medical sciences</topic><topic>Brazil</topic><topic>Centers for Disease Control and Prevention (U.S.) - statistics &amp; numerical data</topic><topic>Europe</topic><topic>food additives</topic><topic>Food Industry - statistics &amp; numerical data</topic><topic>Food toxicology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Nutrition Policy</topic><topic>Product Surveillance, Postmarketing - standards</topic><topic>Product Surveillance, Postmarketing - statistics &amp; numerical data</topic><topic>sweeteners</topic><topic>Toxicology</topic><topic>United States</topic><topic>United States Food and Drug Administration - statistics &amp; numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Butchko, Harriett H.</creatorcontrib><creatorcontrib>Stargel, W.Wayne</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Regulatory toxicology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Butchko, Harriett H.</au><au>Stargel, W.Wayne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aspartame: Scientific Evaluation in the Postmarketing Period</atitle><jtitle>Regulatory toxicology and pharmacology</jtitle><addtitle>Regul Toxicol Pharmacol</addtitle><date>2001-12-01</date><risdate>2001</risdate><volume>34</volume><issue>3</issue><spage>221</spage><epage>233</epage><pages>221-233</pages><issn>0273-2300</issn><eissn>1096-0295</eissn><coden>RTOPDW</coden><abstract>Prior to marketing, the safety of the high-intensity sweetener aspartame for its intended uses as a sweetener and flavor enhancer was demonstrated by the results of over 100 scientific studies in animals and humans. In the postmarketing period, the safety of aspartame was further evaluated through extensive monitoring of intake, postmarketing surveillance of anecdotal reports of alleged health effects, and additional research to evaluate these anecdotal reports and other scientific issues. The results of the extensive intake evaluation in the United States, which was done over an 8-year period, and the results of studies done in other countries demonstrated intakes which were well below the acceptable daily intakes set by the FDA and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of the anecdotal reports of adverse health effects, the first such system for a food additive, revealed that the reported effects were generally mild and also common in the general population and that there was no consistent or unique pattern of symptoms that could be causally linked to consumption of aspartame. Finally, the results of the extensive scientific research done to evaluate these allegations did not show a causal relationship between aspartame and adverse effects. Thus, the weight of scientific evidence confirms that, even in amounts many times what people typically consume, aspartame is safe for its intended uses as a sweetener and flavor enhancer.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>11754527</pmid><doi>10.1006/rtph.2001.1500</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0273-2300
ispartof Regulatory toxicology and pharmacology, 2001-12, Vol.34 (3), p.221-233
issn 0273-2300
1096-0295
language eng
recordid cdi_proquest_miscellaneous_72385919
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
aspartame
Aspartame - administration & dosage
Aspartame - adverse effects
Aspartame - chemistry
Australia
Biological and medical sciences
Brazil
Centers for Disease Control and Prevention (U.S.) - statistics & numerical data
Europe
food additives
Food Industry - statistics & numerical data
Food toxicology
Humans
Medical sciences
Nutrition Policy
Product Surveillance, Postmarketing - standards
Product Surveillance, Postmarketing - statistics & numerical data
sweeteners
Toxicology
United States
United States Food and Drug Administration - statistics & numerical data
title Aspartame: Scientific Evaluation in the Postmarketing Period
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A48%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aspartame:%20Scientific%20Evaluation%20in%20the%20Postmarketing%20Period&rft.jtitle=Regulatory%20toxicology%20and%20pharmacology&rft.au=Butchko,%20Harriett%20H.&rft.date=2001-12-01&rft.volume=34&rft.issue=3&rft.spage=221&rft.epage=233&rft.pages=221-233&rft.issn=0273-2300&rft.eissn=1096-0295&rft.coden=RTOPDW&rft_id=info:doi/10.1006/rtph.2001.1500&rft_dat=%3Cproquest_cross%3E18224948%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18224948&rft_id=info:pmid/11754527&rft_els_id=S0273230001915004&rfr_iscdi=true